 BOSTON, June 01, 2022 GLOBE NEWSWIRE -- Inozyme Pharma, Inc. Nasdaq: INZY, a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization, today announced Axel Bolte, MSc, MBA, the companys co-founder, president, and chief executive officer, will present at the Jefferies Healthcare Conference. The presentation will take place on Wednesday, June 8, 2022 at 2:30 PM ET. 